[8-K] Clorox Company Reports Material Event
On 31 Jul 2025 The Clorox Company (NYSE: CLX) filed a Form 8-K to furnish its fiscal Q4 and full-year 2025 results under Item 2.02 and to provide supplemental information under Item 7.01. While the filing references the earnings press release (Exhibit 99.1) and detailed schedules (Exhibit 99.2), no quantitative data (revenue, EPS, margin, guidance) are included in the body of the report itself; investors must review the exhibits for specifics.
No other corporate events鈥攕uch as acquisitions, restructurings, capital actions or leadership changes鈥攁re disclosed. The document鈥檚 primary purpose is to place the earnings materials into the public domain and satisfy SEC disclosure requirements; market impact therefore depends entirely on the financial figures contained in the attached exhibits, not on the 8-K narrative.
Il 31 luglio 2025, The Clorox Company (NYSE: CLX) ha presentato un modulo 8-K per comunicare i risultati fiscali del quarto trimestre e dell'intero anno 2025 ai sensi della voce 2.02 e per fornire informazioni supplementari ai sensi della voce 7.01. Sebbene il documento faccia riferimento al comunicato stampa sugli utili (Allegato 99.1) e ai dettagliati prospetti (Allegato 99.2), nel corpo del rapporto non sono inclusi dati quantitativi (ricavi, EPS, margine, previsioni); gli investitori devono consultare gli allegati per i dettagli specifici.
Non sono segnalati altri eventi aziendali, come acquisizioni, ristrutturazioni, operazioni sul capitale o cambiamenti nella leadership. Lo scopo principale del documento 猫 rendere pubblici i materiali sugli utili e soddisfare i requisiti di divulgazione della SEC; l'impatto sul mercato dipende quindi esclusivamente dai dati finanziari contenuti negli allegati, non dal testo del modulo 8-K.
El 31 de julio de 2025, The Clorox Company (NYSE: CLX) present贸 un Formulario 8-K para informar sus resultados fiscales del cuarto trimestre y del a帽o completo 2025 bajo el 铆tem 2.02 y para proporcionar informaci贸n suplementaria bajo el 铆tem 7.01. Aunque el documento hace referencia al comunicado de prensa de ganancias (Anexo 99.1) y a los cronogramas detallados (Anexo 99.2), no se incluyen datos cuantitativos (ingresos, BPA, margen, previsiones) en el cuerpo del informe; los inversores deben revisar los anexos para obtener detalles espec铆ficos.
No se divulgan otros eventos corporativos, como adquisiciones, reestructuraciones, acciones de capital o cambios en el liderazgo. El prop贸sito principal del documento es poner los materiales de ganancias en el dominio p煤blico y cumplir con los requisitos de divulgaci贸n de la SEC; por lo tanto, el impacto en el mercado depende completamente de las cifras financieras contenidas en los anexos adjuntos, no de la narrativa del 8-K.
2025雲� 7鞗� 31鞚�, The Clorox Company(NYSE: CLX)電� 頃 2.02鞐� 霐半澕 2025 須岅硠鞐半弰 4攵勱赴 氚� 鞝勳泊 鞐半弰 鞁れ爜鞚� 鞝滉车頃橁碃, 頃 7.01鞐� 霐半澕 氤挫订 鞝曤炒毳� 鞝滉车頃橁赴 鞙勴暣 Form 8-K毳� 鞝滌稖頄堨姷雼堧嫟. 鞝滌稖靹滌棎電� 鞁れ爜 氤措弰鞛愲(歃濍箼鞛愲 99.1)鞕� 靸侅劯 鞚检爼響�(歃濍箼鞛愲 99.2)臧� 鞏戈笁霅橃柎 鞛堨溂雮�, 氤搓碃靹� 氤鸽鞐愲姅 靾橃澋, 欤茧嫻靾滌澊鞚�(EPS), 毵堨, 臧�鞚措崢鞀� 霌� 鞝曤焿鞝� 雿办澊韯瓣皜 韽暔霅橃柎 鞛堨 鞎婌姷雼堧嫟; 韴瀽鞛愲摛鞚� 甑泊鞝侅澑 雮挫毄 頇曥澑鞚� 鞙勴暣 歃濍箼鞛愲毳� 瓴�韱犿暣鞎� 頃╇媹雼�.
鞚胳垬, 甑“臁办爼, 鞛愲掣 臁办箻 霕愲姅 瓴届榿歆� 氤�瓴疥臣 臧欖潃 旮绊儉 旮办梾 鞚措菠韸鸽姅 瓿店皽霅橃 鞎婌晿鞀惦媹雼�. 鞚� 氍胳劀鞚� 欤检殧 氇╈爜鞚� 鞁れ爜 鞛愲毳� 瓿店皽頃橁碃 SEC 瓿奠嫓 鞖旉贝鞚� 於╈”頃橂姅 雿� 鞛堨溂氅�, 鞁滌灔鞐� 氙胳箻電� 鞓來枼鞚� 8-K 氤鸽鞚� 鞎勲媽 觳秬霅� 歃濍箼鞛愲鞚� 鞛 靾橃箻鞐� 鞝勳爜鞙茧 雼牑 鞛堨姷雼堧嫟.
Le 31 juillet 2025, The Clorox Company (NYSE : CLX) a d茅pos茅 un formulaire 8-K pour communiquer ses r茅sultats fiscaux du quatri猫me trimestre et de l鈥檃nn茅e compl猫te 2025 conform茅ment 脿 l鈥檃rticle 2.02 et pour fournir des informations suppl茅mentaires selon l鈥檃rticle 7.01. Bien que le d茅p么t fasse r茅f茅rence au communiqu茅 de presse sur les r茅sultats (Annexe 99.1) et aux tableaux d茅taill茅s (Annexe 99.2), aucun chiffre quantitatif (chiffre d鈥檃ffaires, BPA, marge, pr茅visions) n鈥檈st inclus dans le corps du rapport ; les investisseurs doivent consulter les annexes pour les d茅tails.
Aucun autre 茅v茅nement d鈥檈ntreprise 鈥� tel qu鈥檜ne acquisition, une restructuration, une op茅ration sur le capital ou un changement de direction 鈥� n鈥檈st divulgu茅. L鈥檕bjectif principal du document est de rendre publics les documents relatifs aux r茅sultats et de satisfaire aux exigences de divulgation de la SEC ; l鈥檌mpact sur le march茅 d茅pend donc enti猫rement des chiffres financiers contenus dans les annexes jointes, et non du texte du 8-K.
Am 31. Juli 2025 reichte The Clorox Company (NYSE: CLX) ein Formular 8-K ein, um die Ergebnisse des vierten Quartals und des Gesamtjahres 2025 gem盲脽 Punkt 2.02 mitzuteilen und erg盲nzende Informationen gem盲脽 Punkt 7.01 bereitzustellen. W盲hrend in der Einreichung auf die Gewinnmitteilung (Anlage 99.1) und detaillierte Zeitpl盲ne (Anlage 99.2) verwiesen wird, sind im Text des Berichts selbst keine quantitativen Daten (Umsatz, EPS, Marge, Prognose) enthalten; Investoren m眉ssen die Anlagen f眉r Details pr眉fen.
Es werden keine weiteren Unternehmensereignisse wie 脺bernahmen, Umstrukturierungen, Kapitalma脽nahmen oder F眉hrungswechsel bekannt gegeben. Der Hauptzweck des Dokuments besteht darin, die Gewinnunterlagen 枚ffentlich zug盲nglich zu machen und die Offenlegungspflichten der SEC zu erf眉llen; die Marktauswirkungen h盲ngen daher vollst盲ndig von den in den beigef眉gten Anlagen enthaltenen Finanzzahlen ab, nicht vom 8-K-Text.
- None.
- None.
Insights
TL;DR: Procedural 8-K鈥攅arnings exhibits attached, no numbers inside; impact depends on figures not shown here.
Because the core financial metrics are only embedded in Exhibits 99.1 and 99.2, the filing itself offers no basis to revise estimates or valuation. Investors must consult the press release to assess sales trends, margins, pricing or FY26 guidance. From a trading perspective, the 8-K per se is neutral; price reaction will hinge on the separate earnings data.
TL;DR: Standard compliance filing; demonstrates timely disclosure, no governance red flags detected.
Clorox met its reporting obligations by promptly furnishing the earnings release via Form 8-K. Inclusion of supplemental schedules improves transparency. There are no indications of restatements, internal-control issues, or unusual board actions. Accordingly, governance risk remains unchanged and impact is minimal.
Il 31 luglio 2025, The Clorox Company (NYSE: CLX) ha presentato un modulo 8-K per comunicare i risultati fiscali del quarto trimestre e dell'intero anno 2025 ai sensi della voce 2.02 e per fornire informazioni supplementari ai sensi della voce 7.01. Sebbene il documento faccia riferimento al comunicato stampa sugli utili (Allegato 99.1) e ai dettagliati prospetti (Allegato 99.2), nel corpo del rapporto non sono inclusi dati quantitativi (ricavi, EPS, margine, previsioni); gli investitori devono consultare gli allegati per i dettagli specifici.
Non sono segnalati altri eventi aziendali, come acquisizioni, ristrutturazioni, operazioni sul capitale o cambiamenti nella leadership. Lo scopo principale del documento 猫 rendere pubblici i materiali sugli utili e soddisfare i requisiti di divulgazione della SEC; l'impatto sul mercato dipende quindi esclusivamente dai dati finanziari contenuti negli allegati, non dal testo del modulo 8-K.
El 31 de julio de 2025, The Clorox Company (NYSE: CLX) present贸 un Formulario 8-K para informar sus resultados fiscales del cuarto trimestre y del a帽o completo 2025 bajo el 铆tem 2.02 y para proporcionar informaci贸n suplementaria bajo el 铆tem 7.01. Aunque el documento hace referencia al comunicado de prensa de ganancias (Anexo 99.1) y a los cronogramas detallados (Anexo 99.2), no se incluyen datos cuantitativos (ingresos, BPA, margen, previsiones) en el cuerpo del informe; los inversores deben revisar los anexos para obtener detalles espec铆ficos.
No se divulgan otros eventos corporativos, como adquisiciones, reestructuraciones, acciones de capital o cambios en el liderazgo. El prop贸sito principal del documento es poner los materiales de ganancias en el dominio p煤blico y cumplir con los requisitos de divulgaci贸n de la SEC; por lo tanto, el impacto en el mercado depende completamente de las cifras financieras contenidas en los anexos adjuntos, no de la narrativa del 8-K.
2025雲� 7鞗� 31鞚�, The Clorox Company(NYSE: CLX)電� 頃 2.02鞐� 霐半澕 2025 須岅硠鞐半弰 4攵勱赴 氚� 鞝勳泊 鞐半弰 鞁れ爜鞚� 鞝滉车頃橁碃, 頃 7.01鞐� 霐半澕 氤挫订 鞝曤炒毳� 鞝滉车頃橁赴 鞙勴暣 Form 8-K毳� 鞝滌稖頄堨姷雼堧嫟. 鞝滌稖靹滌棎電� 鞁れ爜 氤措弰鞛愲(歃濍箼鞛愲 99.1)鞕� 靸侅劯 鞚检爼響�(歃濍箼鞛愲 99.2)臧� 鞏戈笁霅橃柎 鞛堨溂雮�, 氤搓碃靹� 氤鸽鞐愲姅 靾橃澋, 欤茧嫻靾滌澊鞚�(EPS), 毵堨, 臧�鞚措崢鞀� 霌� 鞝曤焿鞝� 雿办澊韯瓣皜 韽暔霅橃柎 鞛堨 鞎婌姷雼堧嫟; 韴瀽鞛愲摛鞚� 甑泊鞝侅澑 雮挫毄 頇曥澑鞚� 鞙勴暣 歃濍箼鞛愲毳� 瓴�韱犿暣鞎� 頃╇媹雼�.
鞚胳垬, 甑“臁办爼, 鞛愲掣 臁办箻 霕愲姅 瓴届榿歆� 氤�瓴疥臣 臧欖潃 旮绊儉 旮办梾 鞚措菠韸鸽姅 瓿店皽霅橃 鞎婌晿鞀惦媹雼�. 鞚� 氍胳劀鞚� 欤检殧 氇╈爜鞚� 鞁れ爜 鞛愲毳� 瓿店皽頃橁碃 SEC 瓿奠嫓 鞖旉贝鞚� 於╈”頃橂姅 雿� 鞛堨溂氅�, 鞁滌灔鞐� 氙胳箻電� 鞓來枼鞚� 8-K 氤鸽鞚� 鞎勲媽 觳秬霅� 歃濍箼鞛愲鞚� 鞛 靾橃箻鞐� 鞝勳爜鞙茧 雼牑 鞛堨姷雼堧嫟.
Le 31 juillet 2025, The Clorox Company (NYSE : CLX) a d茅pos茅 un formulaire 8-K pour communiquer ses r茅sultats fiscaux du quatri猫me trimestre et de l鈥檃nn茅e compl猫te 2025 conform茅ment 脿 l鈥檃rticle 2.02 et pour fournir des informations suppl茅mentaires selon l鈥檃rticle 7.01. Bien que le d茅p么t fasse r茅f茅rence au communiqu茅 de presse sur les r茅sultats (Annexe 99.1) et aux tableaux d茅taill茅s (Annexe 99.2), aucun chiffre quantitatif (chiffre d鈥檃ffaires, BPA, marge, pr茅visions) n鈥檈st inclus dans le corps du rapport ; les investisseurs doivent consulter les annexes pour les d茅tails.
Aucun autre 茅v茅nement d鈥檈ntreprise 鈥� tel qu鈥檜ne acquisition, une restructuration, une op茅ration sur le capital ou un changement de direction 鈥� n鈥檈st divulgu茅. L鈥檕bjectif principal du document est de rendre publics les documents relatifs aux r茅sultats et de satisfaire aux exigences de divulgation de la SEC ; l鈥檌mpact sur le march茅 d茅pend donc enti猫rement des chiffres financiers contenus dans les annexes jointes, et non du texte du 8-K.
Am 31. Juli 2025 reichte The Clorox Company (NYSE: CLX) ein Formular 8-K ein, um die Ergebnisse des vierten Quartals und des Gesamtjahres 2025 gem盲脽 Punkt 2.02 mitzuteilen und erg盲nzende Informationen gem盲脽 Punkt 7.01 bereitzustellen. W盲hrend in der Einreichung auf die Gewinnmitteilung (Anlage 99.1) und detaillierte Zeitpl盲ne (Anlage 99.2) verwiesen wird, sind im Text des Berichts selbst keine quantitativen Daten (Umsatz, EPS, Marge, Prognose) enthalten; Investoren m眉ssen die Anlagen f眉r Details pr眉fen.
Es werden keine weiteren Unternehmensereignisse wie 脺bernahmen, Umstrukturierungen, Kapitalma脽nahmen oder F眉hrungswechsel bekannt gegeben. Der Hauptzweck des Dokuments besteht darin, die Gewinnunterlagen 枚ffentlich zug盲nglich zu machen und die Offenlegungspflichten der SEC zu erf眉llen; die Marktauswirkungen h盲ngen daher vollst盲ndig von den in den beigef眉gten Anlagen enthaltenen Finanzzahlen ab, nicht vom 8-K-Text.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
(Exact name of registrant as specified in its charter)
__________________
| (State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer | ||||||
| incorporation) | Identification No.) | |||||||
(Address of principal executive offices) (Zip code)
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
| Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Exhibit | Description | |||||||
99.1 | Press Release dated July 31, 2025 of The Clorox Company | |||||||
99.2 | Supplemental information regarding financial results | |||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
| THE CLOROX COMPANY | |||||||||||
| Date: | July 31, 2025 | By: | /s/ Angela Hilt | ||||||||
| Angela Hilt | |||||||||||
| Executive Vice President – Chief Legal and External Affairs Officer and Corporate Secretary | |||||||||||
Source:
FAQ
When did Clorox (CLX) file its latest Form 8-K?
What items are covered in Clorox鈥檚 July 31 2025 Form 8-K?
Where can investors find Clorox鈥檚 Q4 FY25 financial figures?
Did the 8-K report any mergers, leadership changes or legal issues?
